Figure 5.
FG-4592 pretreatment increases the expression of Nrf2-mediated SLC7A11 and ferroportin protein expression. (a) Western blotting of SLC7A11. (b) Semiquantitative measurements of SLC7A11. (c) Western blotting of ferroportin. (d) Semiquantitative measurements of ferroportin. The values are expressed as the means ± SEM. ∗P < 0.05 versus the control group. #P < 0.05 versus the FG-4592 group. &P < 0.05 versus the FA group.